The lowdown on the pill that’s helping prevent HIV before it starts


Miranda Elliott writes at CBC Life:

In the last 30 years, the HIV pandemic has claimed the lives of more than 35 million people.  Now, thanks to global efforts to reduce deaths and prevent new infections, it seems like an HIV-free future might come sooner than anyone expected. In 2014, UNAIDS embarked on a strategy to eradicate HIV by 2030, an achievement that seems almost unthinkable twenty years ago, when deaths from the virus were at their peak.

One of the most exciting developments in the fight against HIV is pre-exposure prophylaxis, aka PrEP for short.  Approved by Health Canada in 2016, PrEP isn’t a new invention, but an innovative approach to preventing the spread of the virus using existing medication. Simply put, PrEP is the daily use of the anti-HIV drug Truvada by people who don’t yet have the virus. And it’s incredibly effective: if used consistently and as directed, studies show it can reduce the risk of HIV transmission by between 85% and 92%.

This is an especially big deal for men who have unprotected sex with men, one of the groups at the highest risk of contracting HIV in North America. But for millions of gay and bisexual men, PrEP is more than just a medical solution. Len Tooley, a Counsellor and Public Health Research Coordinator and a PrEP user, says the drug marks the end of a dark chapter in gay and bisexual history, in which sex could mean a death sentence.

Read more


Please enter your comment!
Please enter your name here